ACC.18 Joint ACC/JACC Late-Breaking Clinical Trials

This CME certified session from the American College of Cardiology’s Annual Scientific Session is available on demand courtesy of Sanofi Regeneron and is presented in its original, unedited form. It may not be reproduced, republished or modified in any way. Sanofi Regeneron had no control over or input into the content of the session. CME credit is not available to online viewers.

Download the Slides

• Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial
• Efficacy of a Wearable Cardioverter-Defibrillator after Myocardial Infarction: Results of the Vest Prevention of Early Sudden Death Trial (VEST)